Recombinant Human SREK1 Protein，His

SREK1, or SREK1 (Suppressor of Ras Efferent Kinase 1), is a protein that plays a critical role in cellular signaling pathways, particularly in relation to cancer and cellular stress responses. Research has shown that SREK1 is involved in modulating various physiological processes, including cell proliferation, differentiation, and apoptosis. As a member of the Ras signaling pathway, SREK1 acts as a key regulator that can influence the tumorigenic potential of cells by interacting with other signaling molecules and transcription factors. Its expression levels have been linked to multiple cancers, highlighting its potential as a biomarker for cancer diagnosis and prognosis. Recent studies have focused on the recombinant expression of SREK1 to understand its structural and functional properties better, paving the way for therapeutic interventions. The production of recombinant SREK1 allows for in-depth investigations into its mechanistic roles in disease pathways, offering insights into how targeted therapies could be developed for malignancies where SREK1 is dysregulated. Exploring the biophysical characteristics of SREK1, alongside its association with other signal transduction proteins, could also lead to novel strategies for combating cancer and improving therapeutic efficacy. Overall, ongoing research into SREK1 recombinant protein not only enhances our understanding of intracellular signaling networks but also presents promising avenues for innovative cancer treatment options.